Most importantly, our results demonstrated that HoxA9 could bind to the promoters of BNP and β-MHC, two typical cardiac hypertrophic markers, suggesting that HoxA9 serves as a transcription factor of BNP and β-MHC to facilitate the development of cardiac hypertrophy. Here, NPPB is linked to cardiac hypertrophy.